0001666071-20-000306.txt : 20201216
0001666071-20-000306.hdr.sgml : 20201216
20201216183000
ACCESSION NUMBER: 0001666071-20-000306
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201214
FILED AS OF DATE: 20201216
DATE AS OF CHANGE: 20201216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laube Lynne Marie
CENTRAL INDEX KEY: 0001730687
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 201393676
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_160816138763891.xml
FORM 4
X0306
4
2020-12-14
0
0001666071
Cardlytics, Inc.
CDLX
0001730687
Laube Lynne Marie
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
1
1
0
0
Chief Executive Officer
Common Stock
2020-12-14
4
S
0
752
134.34
D
306254
D
Common Stock
2020-12-14
4
S
0
848
135.36
D
305406
D
Common Stock
2020-12-14
4
S
0
1612
136.44
D
303794
D
Common Stock
2020-12-14
4
S
0
3692
137.53
D
300102
D
Common Stock
2020-12-14
4
S
0
2896
138.34
D
297206
D
Common Stock
2020-12-14
4
S
0
200
139.07
D
297006
D
Common Stock
14565
I
See Footnote
Common Stock
14565
I
See Footnote
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $133.82 to $134.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8) to this Form 4.
Includes 158 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $134.89 to $135.80, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $135.90 to $136.80, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $136.94 to $137.93, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $137.95 to $138.91, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $139.03 to $139.11, inclusive.
The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright.
The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright.
/s/ Kirk Somers, Attorney-in-Fact
2020-12-16